Cargando…
Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C
To improve treatment of metastatic prostate cancer, the biology of metastases needs to be understood. We recently described three subtypes of prostate cancer bone metastases (MetA‐C), based on differential gene expression. The aim of this study was to verify the clinical relevance of these subtypes...
Autores principales: | Thysell, Elin, Köhn, Linda, Semenas, Julius, Järemo, Helena, Freyhult, Eva, Lundholm, Marie, Thellenberg Karlsson, Camilla, Damber, Jan‐Erik, Widmark, Anders, Crnalic, Sead, Josefsson, Andreas, Welén, Karin, Nilsson, Rolf J. A., Bergh, Anders, Wikström, Pernilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847984/ https://www.ncbi.nlm.nih.gov/pubmed/34889043 http://dx.doi.org/10.1002/1878-0261.13158 |
Ejemplares similares
-
Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy
por: Wikström, Pernilla, et al.
Publicado: (2022) -
Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328
por: Järemo, Helena, et al.
Publicado: (2023) -
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2019) -
A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression
por: Wänman, Johan, et al.
Publicado: (2022) -
Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants
por: Jernberg, Emma, et al.
Publicado: (2013)